{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T18:14:18Z","timestamp":1778523258930,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T00:00:00Z","timestamp":1546473600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s11255-018-02065-2","type":"journal-article","created":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T00:49:27Z","timestamp":1546476567000},"page":"483-490","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Association of neutrophil-to-lymphocyte ratio with early renal dysfunction and albuminuria among diabetic patients"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4674-0787","authenticated-orcid":false,"given":"Ryuichi","family":"Kawamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Ninomiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asuka","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taichi","family":"Akase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Kasai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomo","family":"Kusunoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Ohtsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teru","family":"Kumagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,3]]},"reference":[{"key":"2065_CR1","first-page":"28","volume":"4","author":"SB Ghaderian","year":"2015","unstructured":"Ghaderian SB, Hayati F, Shayanpour S, Beladi SS, Mousavi (2015) Diabetes and end-stage renal disease; a review article on new concepts. J Renal Inj Prev 4:28\u201333","journal-title":"J Renal Inj Prev"},{"key":"2065_CR2","doi-asserted-by":"publisher","first-page":"714","DOI":"10.2337\/dc07-2124","volume":"31","author":"A Juutilainen","year":"2008","unstructured":"Juutilainen A, Lehto S, Ronnemaa T, Pyorala K, Laakso M (2008) Similarity of the impact of type 1 and type 2 diabetes on cardiovascular mortality in middle-aged subjects. Diabetes Care 31:714\u2013719","journal-title":"Diabetes Care"},{"key":"2065_CR3","first-page":"49","volume":"5","author":"O Gheith","year":"2016","unstructured":"Gheith O, Farouk N, Nampoory N, Halim MA, Al-Otaibi T (2016) Diabetic kidney disease: world wide difference of prevalence and risk factors. J Nephropharmacol 5:49\u201356","journal-title":"J Nephropharmacol"},{"key":"2065_CR4","doi-asserted-by":"publisher","first-page":"393","DOI":"10.4239\/wjd.v5.i3.393","volume":"5","author":"MB Duran-Salgado","year":"2014","unstructured":"Duran-Salgado MB, Rubio-Guerra AF (2014) Diabetic nephropathy and inflammation. World J Diabetes 5:393\u2013398","journal-title":"World J Diabetes"},{"key":"2065_CR5","doi-asserted-by":"publisher","first-page":"F716","DOI":"10.1152\/ajprenal.00314.2016","volume":"312","author":"R Pichler","year":"2017","unstructured":"Pichler R, Afkarian M, Dieter BP, Tuttle KR (2017) Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets. Am J Physiol Renal Physiol 312:F716\u2013F731","journal-title":"Am J Physiol Renal Physiol"},{"key":"2065_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1586\/erc.12.159","volume":"11","author":"T Bhat","year":"2013","unstructured":"Bhat T, Teli S, Rijal J, Bhat H, Raza M, Khoueiry G, Meghani M, Akhtar M, Costantino T (2013) Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev Cardiovasc Ther 11:55\u201359","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2065_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.atherosclerosis.2013.02.017","volume":"228","author":"N Sen","year":"2013","unstructured":"Sen N, Afsar B, Ozcan F, Buyukkaya E, Isleyen A, Akcay AB, Yuzgecer H, Kurt M, Karakas MF, Basar N, Hajro E, Kanbay M (2013) The neutrophil to lymphocyte ratio was associated with impaired myocardial perfusion and long term adverse outcome in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Atherosclerosis 228:203\u2013210","journal-title":"Atherosclerosis"},{"key":"2065_CR8","doi-asserted-by":"publisher","first-page":"500","DOI":"10.5603\/CJ.a2013.0148","volume":"21","author":"AC Sawant","year":"2014","unstructured":"Sawant AC, Adhikari P, Narra SR, Srivatsa SS, Mills PK, Srivatsa SS (2014) Neutrophil to lymphocyte ratio predicts short- and long-term mortality following revascularization therapy for ST elevation myocardial infarction. Cardiol J 21:500\u2013508","journal-title":"Cardiol J"},{"key":"2065_CR9","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1586\/14779072.2016.1154788","volume":"14","author":"ME Afari","year":"2016","unstructured":"Afari ME, Bhat T (2016) Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: an update. Expert Rev Cardiovasc Ther 14:573\u2013577","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2065_CR10","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00059-015-4399-8","volume":"41","author":"C Yu","year":"2016","unstructured":"Yu C, Chen M, Chen Z, Lu G (2016) Predictive and prognostic value of admission neutrophil-to-lymphocyte ratio in patients with CHD. Herz 41:605\u2013613","journal-title":"Herz"},{"issue":"Suppl 1","key":"2065_CR11","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1016\/j.ihj.2017.01.020","volume":"69","author":"R Bajari","year":"2017","unstructured":"Bajari R, Tak S (2017) Predictive prognostic value of neutrophil-lymphocytes ratio in acute coronary syndrome. Indian Heart J 69(Suppl 1):S46\u2013S50","journal-title":"Indian Heart J"},{"key":"2065_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.clinbiochem.2017.11.008","volume":"52","author":"CH Dong","year":"2018","unstructured":"Dong CH, Wang ZM, Chen SY (2018) Neutrophil to lymphocyte ratio predict mortality and major adverse cardiac events in acute coronary syndrome: a systematic review and meta-analysis. Clin Biochem 52:131\u2013136","journal-title":"Clin Biochem"},{"key":"2065_CR13","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1177\/0003319712455216","volume":"64","author":"B Azab","year":"2013","unstructured":"Azab B, Chainani V, Shah N, McGinn JT (2013) Neutrophil-lymphocyte ratio as a predictor of major adverse cardiac events among diabetic population: a 4-year follow-up study. Angiology 64:456\u2013465","journal-title":"Angiology"},{"key":"2065_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1053\/j.ajkd.2010.02.344","volume":"56","author":"M Horio","year":"2010","unstructured":"Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S (2010) Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates. Am J Kidney Dis 56:32\u201338","journal-title":"Am J Kidney Dis"},{"key":"2065_CR15","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3109\/0886022X.2012.668741","volume":"34","author":"B Azab","year":"2012","unstructured":"Azab B, Daoud J, Naeem FB, Nasr R, Ross J, Ghimire P, Siddiqui A, Azzi N, Rihana N, Abdallah M, Azzi N, Patel P, Kleiner M, El-Sayegh S (2012) Neutrophil-to-lymphocyte ratio as a predictor of worsening renal function in diabetic patients (3-year follow-up study). Ren Fail 34:571\u2013576","journal-title":"Ren Fail"},{"key":"2065_CR16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/MAJ.0b013e31828365cc","volume":"347","author":"B Afsar","year":"2014","unstructured":"Afsar B (2014) The relationship between neutrophil lymphocyte ratio with urinary protein and albumin excretion in newly diagnosed patients with type 2 diabetes. Am J Med Sci 347:217\u2013220","journal-title":"Am J Med Sci"},{"key":"2065_CR17","first-page":"1794","volume":"7","author":"EM Akbas","year":"2014","unstructured":"Akbas EM, Demirtas L, Ozcicek A, Timuroglu A, Bakirci EM, Hamur H, Ozcicek F, Turkmen K (2014) Association of epicardial adipose tissue, neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with diabetic nephropathy. Int J Clin Exp Med 7:1794\u20131801","journal-title":"Int J Clin Exp Med"},{"key":"2065_CR18","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/cen.12576","volume":"82","author":"W Huang","year":"2015","unstructured":"Huang W, Huang J, Liu Q, Lin F, He Z, Zeng Z, He L (2015) Neutrophil-lymphocyte ratio is a reliable predictive marker for early-stage diabetic nephropathy. Clin Endocrinol 82:229\u2013233","journal-title":"Clin Endocrinol"},{"key":"2065_CR19","first-page":"250","volume":"3","author":"E Youssef Moursy","year":"2015","unstructured":"Youssef Moursy E (2015) Relationship between neutrophil-lymphocyte ratio and microvascular complications in Egyptian patients with type 2 diabetes. Am J Intern Med 3:250\u2013255","journal-title":"Am J Intern Med"},{"key":"2065_CR20","doi-asserted-by":"publisher","first-page":"571","DOI":"10.5114\/aoms.2016.59931","volume":"12","author":"C Kahraman","year":"2016","unstructured":"Kahraman C, Kahraman NK, Aras B, Cosgun S, Gulcan E (2016) The relationship between neutrophil-to-lymphocyte ratio and albuminuria in type 2 diabetic patients: a pilot study. Arch Med Sci AMS 12:571\u2013575","journal-title":"Arch Med Sci AMS"},{"key":"2065_CR21","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1042\/CS20080394","volume":"116","author":"A Rivero","year":"2009","unstructured":"Rivero A, Mora C, Muros M, Garcia J, Herrera H, Navarro-Gonzalez JF (2009) Pathogenic perspectives for the role of inflammation in diabetic nephropathy. Clin Sci (Lond) 116:479\u2013492","journal-title":"Clin Sci (Lond)"},{"key":"2065_CR22","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/dmrr.2380","volume":"29","author":"T Fujita","year":"2013","unstructured":"Fujita T, Hemmi S, Kajiwara M, Yabuki M, Fuke Y, Satomura A, Soma M (2013) Complement-mediated chronic inflammation is associated with diabetic microvascular complication. Diabetes Metab Res Rev 29:220\u2013226","journal-title":"Diabetes Metab Res Rev"},{"key":"2065_CR23","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/146154","volume":"2012","author":"AK Lim","year":"2012","unstructured":"Lim AK, Tesch GH (2012) Inflammation in diabetic nephropathy. Mediators Inflamm 2012:146154","journal-title":"Mediators Inflamm"},{"key":"2065_CR24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1177\/1076029612459675","volume":"20","author":"E Buyukkaya","year":"2014","unstructured":"Buyukkaya E, Karakas MF, Karakas E, Akcay AB, Tanboga IH, Kurt M, Sen N (2014) Correlation of neutrophil to lymphocyte ratio with the presence and severity of metabolic syndrome. Clin Appl Thromb Hemost 20:159\u2013163","journal-title":"Clin Appl Thromb Hemost"},{"key":"2065_CR25","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1177\/1076029612452116","volume":"20","author":"H Kaya","year":"2014","unstructured":"Kaya H, Ertas F, Islamoglu Y, Kaya Z, Atilgan ZA, Cil H, Caliskan A, Aydin M, Oylumlu M, Soydinc MS (2014) Association between neutrophil to lymphocyte ratio and severity of coronary artery disease. Clin Appl Thromb Hemost 20:50\u201354","journal-title":"Clin Appl Thromb Hemost"},{"key":"2065_CR26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1177\/1076029615569568","volume":"22","author":"S Balta","year":"2016","unstructured":"Balta S, Celik T, Mikhailidis DP, Ozturk C, Demirkol S, Aparci M, Iyisoy A (2016) The relation between atherosclerosis and the neutrophil-lymphocyte ratio. Clin Appl Thromb Hemost 22:405\u2013411","journal-title":"Clin Appl Thromb Hemost"},{"key":"2065_CR27","doi-asserted-by":"publisher","first-page":"e8624","DOI":"10.1097\/MD.0000000000008624","volume":"96","author":"J Zhang","year":"2017","unstructured":"Zhang J, Ren Q, Song Y, He M, Zeng Y, Liu Z, Xu J (2017) Prognostic role of neutrophil-lymphocyte ratio in patients with acute ischemic stroke. Medicine 96:e8624","journal-title":"Medicine"},{"key":"2065_CR28","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.3748\/wjg.v21.i9.2807","volume":"21","author":"JJ Yang","year":"2015","unstructured":"Yang JJ, Hu ZG, Shi WX, Deng T, He SQ, Yuan SG (2015) Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis. World J Gastroenterol 21:2807\u20132815","journal-title":"World J Gastroenterol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-018-02065-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-018-02065-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-018-02065-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T19:12:27Z","timestamp":1577992347000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-018-02065-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["2065"],"URL":"https:\/\/doi.org\/10.1007\/s11255-018-02065-2","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,3]]},"assertion":[{"value":"30 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee at which the studies conducted.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"We obtained consent through opt-out procedure from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}